Last scanned
Domain Age
Daily Visitors
Global Rank
Updated:
EMPLICITI® (elotuzumab) | Healthcare Professional Website
EMPLICITI® (elotuzumab) is a treatment to be used with Pd or Rd for certain adults with relapsed or refractory multiple myeloma. Please see Indication and Important Safety Info.
This website is hosted with Incapsula Inc, which reserves the following IP addresses for emplicitihcp.com: 45.60.150.161. Moreover, DNS used with this website include ns1.bms.com, ns2.bms.com, ns3.bms.com, ns4.bms.com. Subnet identifier ranges from 45.60.0.0 to 45.60.255.255. Classless Inter-Domain Routing (CIDR) is 45.60.0.0/16. ARIN net type is Direct Allocation.
Last scanned
Domain Age
Daily Visitors
Global Rank
ns1.bms.com
ns2.bms.com
ns3.bms.com
ns4.bms.com
{{value}}
2015-11-04
2023-11-04
CSC CORPORATE DOMAINS, INC.
{{value}}
The registrar of emplicitihcp.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2023-11-04. According to open source data, you can reach the owner at dns.admin@BMS.COM but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.
N/A
N/A
N/A
267
N/A
N/A
130.9K
534
N/A
N/A
N/A
N/A